Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Restart
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(267)
•••
Comment by LaserStock29on Jul 10, 2020 2:45pm
164 Views
Post# 31253036

RE:RE:Restart

RE:RE:Restart
Ponching wrote: PMH restarted as of May 29th. Though they only mentioned treating for 2nd treatment. IMO they won't be doing 2nd treatment if their clinic is not ready to accept patients at that time.
The first treatment for patients takes a little longer due to the 30days screening period prior to the 1st treatment. 


Again for the 2nd treatments in covid time it makes sense since May 29th too play catch up and treat those already due up. March 3rd P1, April 7 P2, May P345, June P6 July 789 Aug Sept P10-P12 roughly.................... then since Nova scotia been covid free for basically a month that lake cant be empty enrol 5 and get going with new treatments there....... this pitiful sac of garbage excuses I'm sick of
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities